These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 21376648

  • 1. Discovery of new renin inhibitory leads via sequential pharmacophore modeling, QSAR analysis, in silico screening and in vitro evaluation.
    Al-Nadaf AH, Taha MO.
    J Mol Graph Model; 2011 Apr; 29(6):843-64. PubMed ID: 21376648
    [Abstract] [Full Text] [Related]

  • 2. Discovery of new MurF inhibitors via pharmacophore modeling and QSAR analysis followed by in-silico screening.
    Taha MO, Atallah N, Al-Bakri AG, Paradis-Bleau C, Zalloum H, Younis KS, Levesque RC.
    Bioorg Med Chem; 2008 Feb 01; 16(3):1218-35. PubMed ID: 17988876
    [Abstract] [Full Text] [Related]

  • 3. Discovery of new cholesteryl ester transfer protein inhibitors via ligand-based pharmacophore modeling and QSAR analysis followed by synthetic exploration.
    Abu Khalaf R, Abu Sheikha G, Bustanji Y, Taha MO.
    Eur J Med Chem; 2010 Apr 01; 45(4):1598-617. PubMed ID: 20116902
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacophore and QSAR modeling of estrogen receptor beta ligands and subsequent validation and in silico search for new hits.
    Taha MO, Tarairah M, Zalloum H, Abu-Sheikha G.
    J Mol Graph Model; 2010 Jan 01; 28(5):383-400. PubMed ID: 19850503
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening.
    Taha MO, Bustanji Y, Al-Bakri AG, Yousef AM, Zalloum WA, Al-Masri IM, Atallah N.
    J Mol Graph Model; 2007 Mar 01; 25(6):870-84. PubMed ID: 17035054
    [Abstract] [Full Text] [Related]

  • 10. Combining ligand-based pharmacophore modeling, quantitative structure-activity relationship analysis and in silico screening for the discovery of new potent hormone sensitive lipase inhibitors.
    Taha MO, Dahabiyeh LA, Bustanji Y, Zalloum H, Saleh S.
    J Med Chem; 2008 Oct 23; 51(20):6478-94. PubMed ID: 18808096
    [Abstract] [Full Text] [Related]

  • 11. Elaborate ligand-based modeling reveals new nanomolar heat shock protein 90α inhibitors.
    Al-Sha'er MA, Taha MO.
    J Chem Inf Model; 2010 Sep 27; 50(9):1706-23. PubMed ID: 20831219
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Extensive ligand-based modeling and in silico screening reveal nanomolar inducible nitric oxide synthase (iNOS) inhibitors.
    Suaifan GA, Shehadehh M, Al-Ijel H, Taha MO.
    J Mol Graph Model; 2012 Jul 27; 37():1-26. PubMed ID: 22609742
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ligand-based modeling of diverse aryalkylamines yields new potent P-glycoprotein inhibitors.
    AlQudah DA, Zihlif MA, Taha MO.
    Eur J Med Chem; 2016 Mar 03; 110():204-23. PubMed ID: 26840362
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.